USD10
CNTX Shares
About Context TherapeuticsContext Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
USD10
CNTX Shares
About Context TherapeuticsContext Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$36.55M
OPEN PRICE
$0.41
LOW (1Y)
$0.3807
HIGH (1Y)
$3.62
LOW (24H)
$0.3807
HIGH (24H)
$0.4228
VOLUME (24H)
$3.04M
166.47%
Price history
Time | Price | Change |
|---|---|---|
Today | $0.41 | |
1 Day | $0.3837 | |
1 Week | $0.5001 | |
1 Month | $0.5975 | |
1 Year | $0.8498 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.